| Literature DB >> 7302612 |
J Howell, M Clozel, J V Aranda.
Abstract
The desirable effects of methylxanthine use in the neonate, appropriately prescribed and monitored, outweigh the importance of adverse effects. This view assumes that pharmacologic manipulation of apnea of prematurity is in itself a desirable goal and clearly superior to treatment of apneic episodes when they occur. While a considerable body of evidence supports this current practice, conclusive documentation awaits long-term follow-up studies.Entities:
Mesh：
Substances：
Year: 1981 PMID： 7302612
Source DB: PubMed Journal: Semin Perinatol ISSN： 0146-0005 Impact factor: 3.300